NTLA

Intellia Therapeutics Inc

Jun 12 • 04:00PM ET

12.11

-0.24 -1.94 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BEAM CRSP EDIT VIR BMRN IONS ALNY INCY VRTX SNDX

| Held by: ARKK VTI XBI VB ARKG IWM VBK VXF IBB IWN

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.53	Insider Own	4.39%	Shs Outstand	139.72M	Perf Week	-10.56%
Market Cap	1.69B	Forward P/E	-	EPS next Y	-1.85	Insider Trans	1.06%	Shs Float	133.59M	Perf Month	-15.20%
Enterprise Value	1.40B	PEG	-	EPS next Q	-0.81	Inst Own	76.22%	Short Float	36.32%	Perf Quarter	-5.09%
Income	-394.60M	P/S	25.60	EPS this Y	15.48%	Inst Trans	4.79%	Short Ratio	8.59	Perf Half Y	29.24%
Sales	66.09M	P/B	2.35	EPS next Y	42.57%	ROA	-45.23%	Short Interest	48.52M	Perf YTD	34.71%
Book/sh	5.16	P/C	4.50	EPS next 5Y	43.91%	ROE	-56.34%	52W High	28.25 -57.13%	Perf Year	45.03%
Cash/sh	2.69	P/FCF	-	EPS past 3/5Y	14.82% -9.70%	ROIC	-57.83%	52W Low	7.95 52.33%	Perf 3Y	-72.23%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.09% 3.13%	Gross Margin	76.32%	Volatility	8.18% 8.24%	Perf 5Y	-85.80%
Dividend TTM	-	EV/Sales	21.13	EPS Y/Y TTM	32.42%	Oper. Margin	-636.56%	ATR (14)	1.09	Perf 10Y	-55.21%
Dividend Ex-Date	-	Quick Ratio	6.10	Sales Y/Y TTM	45.04%	Profit Margin	-597.04%	RSI (14)	41.93	Recom	2.23
Dividend Gr. 3/5Y	- -	Current Ratio	6.10	EPS Q/Q	26.48%	SMA20	-7.04%	Beta	1.82	Target Price	26.61
Payout	-	Debt/Eq	0.13	Sales Q/Q	-9.50%	SMA50	-11.14%	Rel Volume	1.80	Prev Close	12.35
Employees	377	LT Debt/Eq	0.10	Earnings	May 11 BMO	SMA200	-9.59%	Avg Volume	5.65M	Price	12.11
IPO	May 06, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.06% 8.99%	Trades		Volume	10,190,863	Change	-1.94%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)